AI in Drug Development helps Pharma Cut Trial Admin Time

Original Article by Maggie Fick and Michael Erman | Reuters | 26 January 2026

AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.

AI in Drug Development is cutting trial setup and regulatory paperwork, with Novartis and GSK citing major time and cost savings.

Subscription Required

You must be a subscriber to access all of this content.

View Subscriptions

Already a subscriber? Log in here